Table 2 An exploration of KEGG cancer pathways.
| Â | Â | Two data sets | Three data sets | ||||
|---|---|---|---|---|---|---|---|
KEGG cancer pathways | U/D | CES | Diff. | FDR | CES | Diff. | FDR |
PPAR signaling * | down | 0.671 | >0.1 | 0.194 | 0.563 | >0.1 | 0.210 |
MAPK signaling ** | down | 0.639 | >0.1 | 0.209 | 0.857 | >0.1 | 0.063 |
ERBB signaling * | up | 0.629 | >0.1 | 0.119 | 0.581 | >0.1 | 0.188 |
Calcium signaling ** | down | 0.925 | >0.1 | 0.051 | 0.694 | >0.1 | 0.153 |
Cytokine-cytokine receptor interaction *** | down | 0.717 | >0.1 | 0.172 | 0.943 | >0.1 | 0.022 |
Cell cycle *** | up | 0.998 | >0.1 | <0.001 | 0.959 | >0.1 | 0.012 |
p53 signaling *** | up | 0.999 | >0.1 | <0.001 | 0.944 | >0.1 | 0.018 |
MTOR signaling * | down | 0.724 | >0.1 | 0.167 | 0.611 | >0.1 | 0.193 |
Apoptosis * | down |  | ≤ 0.1 |  | 0.776 | >0.1 | 0.102 |
WNT signaling *** | down |  | ≤ 0.1 |  | 0.888 | >0.1 | 0.048 |
TGF-β signaling | down |  | ≤ 0.1 |  | 0.521 | >0.1 | 0.236 |
VEGF signaling *** | down | 0.784 | >0.1 | 0.136 | 0.919 | >0.1 | 0.033 |
Focal adhesion *** | up | >0.999 | >0.1 | <0.001 | 0.830 | >0.1 | 0.077 |
ECM receptor interaction *** | up | 0.996 | >0.1 | <0.001 | 0.977 | >0.1 | 0.005 |
Adherens junction * | up | 0.646 | >0.1 | 0.114 |  | ≤ 0.1 |  |
JAK-STAT signaling *** | down | 0.875 | >0.1 | 0.082 | 0.901 | >0.1 | 0.044 |